Lipoglycopeptide Antibacterial class drugs
3 results
Dalvance (dalbavancin)
(Dalbavancin)Allergan, Inc.
Usage: DALVANCE® is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults and pediatric patients caused by specific susceptible Gram-positive bacteria, including Staphylococcus aureus and Enterococcus faecalis. Its use aims to reduce drug-resistant bacteria development.
Kimyrsa (oritavancin diphosphate)
(oritavancin diphosphate)Melinta Therapeutics, LLC
Usage: KIMYRSA® is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults caused by specific Gram-positive bacteria, including methicillin-susceptible and resistant Staphylococcus aureus, as well as other susceptible Streptococcus and Enterococcus species. It should be used judiciously to prevent antibiotic resistance.
Orbactiv (oritavancin)
(oritavancin)Melinta Therapeutics, LLC
Usage: ORBACTIV® (oritavancin) is indicated for treating adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus and various Streptococcus species. It should be used judiciously to prevent drug resistance.